Menninger Clinic Continuing Education Conference, Houston, Texas
March 28, 2008
Purpose of the conference:
To present an array of contemporary, clinical approaches for the treatment of borderline personality disorder.
Conference Program
Welcome remarks
John M. Oldham, MD, MS
Senior vice president and chief of staff, The Menninger Clinic; professor of psychiatry and executive vice chair, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas.
Borderline Personality Disorder: Overview of Recent Research Findings
Presenter: John M. Oldham, MD, MS
Senior vice president and chief of staff, The Menninger Clinic; professor of psychiatry and executive vice chair, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas
Objectives
1. Recognize current research findings regarding the etiology and neurobiology of borderline personality disorder (BPD).
2. Describe evidence-based recommendations for treatment of patients with BPD.
3. Identify longitudinal studies of BPD that support new ways of categorizing and defining the disorder, which will guide the DSM-V planning process.
Mentalizing in the Treatment of BPD
Presenter: Jon G. Allen, PhD
Director of psychology, The Menninger Clinic; professor of psychiatry and Helen Malsin Palley Chair in Mental Health Research, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas
Objectives
1. Explain how attachment relationships influence mentalizing development.
2. Discuss the basic principles of mentalizing-focused, BPD treatment.
Evidence-Based Treatment of BPD
Presenter: Glen O. Gabbard, MD
Brown Foundation Chair of Psychoanalysis and professor of psychiatry, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine; director, Baylor Psychiatric Clinic, Houston, Texas
Objectives
1. Discuss the research base for use of medications in BPD treatment.
2. Contrast the types of psychotherapy that have been shown to be efficacious with patients who have BPD.
Family Psychoeducation for BPD
Presenter: Perry D. Hoffman, PhD
President, National Education Alliance for Borderline Personality Disorder, Rye, New York
Objectives
1. Acknowledge the impact of BPD on family members.
2. Identify the role of family psychoeducation for relatives of persons with BPD.
3. Describe specific skills to increase family members’ coping strategies.
Borderline Personality as a Self-Other Representational Disturbance
Presenter: Donna S. Bender, PhD
Research director, Institute for Mental Health Research, Phoenix, Arizona; research associate professor of psychiatry, Department of Psychiatry, University of Arizona, Tucson, Arizona
Objectives
1. Identify the role of mental representations of self and others in the context of BPD.
2. Consider treatment implications of a self-other representational model of BPD.
New Developments in the Neurobiology of BPD
Presenter: Larry J. Siever, MD
Professor of psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, New York; director, Mental Illness Research, Education and Clinical Center (MIRECC), Bronx VA Medical Center, Bronx, New York, New York
Objectives
1. Recognize that BPDs have neurobiologic substrates.
2. Acknowledge that these substrates provide a rationale for pharmacotherapy.
3. Accept that the neurobiology of BPDs has implications for psychosocial treatment.
Borderline Personality Disorder in DSM-V
Presenter: Andrew E. Skodol, MD
President, Institute for Mental Health Research, Phoenix, Arizona; research professor of psychiatry, Department of Psychiatry, University of Arizona College of Medicine, Tucson, Arizona
Objectives
1. Describe the goals for the DSM-V and the process of revision.
2. Explain how BPD might be described and diagnosed according to alternative models being considered for DSM-V psychiatric diagnoses.
Recent Comments